| |
|---|
March 7, 2008 12:00 AM
“Being able to not just survive, but to thrive and flourish during the second half of life means facing life honestly, resource-fully, and creatively.” Barbara was able to experience, and encourage, all of these attri-butes during her internship with the Fountain Hills Parkinson Support Group. She con-ceived, developed, and taught a ten-week course in Expressive Arts for people with Parkinson’s. To say it went exceedingly well would be an understatement!
Read More... |
|
March 7, 2008 12:00 AM
With upbeat Latin music in the background, John O’Donnell moved his feet and hips as his wife counted off the steps.
“One, two, cha, cha, cha,” said Karen O’Donnell.
The Sun Citian glided across the floor under the watchful eye of instructor Kathleen Henry.
For an hour every week, John O’Donnell and several other Parkinson’s disease patients take to the floor at Shepherd of the Desert Lutheran Church in Sun City for ballroom dance lessons. The sessions are offered by the Muhammad Ali Parkinson Center at St. Joseph’s Hospital to improve the quality of life of Parkinson’s patients by boosting their self-esteem, flexibility, balance, stamina and posture.
Read More... |
|
October 19, 2007 12:00 AM
UCB, Inc. presented data from two clinical trials that showed Neupro® (Rotigotine Transdermal System), a once-daily non-ergolinic dopamine agonist patch, is effective in controlling early morning motor impairment, provides improvement in sleep quality, and is generally well-tolerated for long-term use in patients with Parkinson's disease. Studies examining patients who have either early or advanced-stage Parkinson's disease were also presented.
Read More... |
|
October 19, 2007 12:00 AM
In a finding that may lead to potential new treatments for diseases such as Alzheimer's and Parkinson's, researchers at the Picower Institute for Learning and Memory at MIT report an unexpected role in the brain for a well-known protein.
Read More... |
|
October 19, 2007 12:00 AM
Tiantan Puhua Neurosurgical Hospital, the world's leading center for effective treatment of Parkinson's disease using adult retinal stem cells, here announced that four more international patients returned home from China with a significant reduction in their debilitating Parkinson's disease symptoms. These success stories clearly demonstrate stem cells can effectively be used to treat afflictions like Parkinson's in addition to many other neurological disorders. More details and videos of the four patients' progress can be found at http://www.stemcellschina.com.
Read More... |
|
October 19, 2007 12:00 AM
The discovery of a relationship between two cell enzymes and their role in keeping the cell's energy generating machinery working smoothly could provide a new target for development of therapies for Parkinson's disease (PD
Read More... |
|
October 19, 2007 12:00 AM
NEW YORK (Reuters Health) - A short screening test, developed by a Belgian team, which measures four clinical variables can accurately predict the fitness of patients with Parkinson's disease to drive, according to findings published in the current issue of the journal Neurology.
Read More... |
|
October 18, 2007 12:00 AM
Relatives of patients with Parkinson’s disease may have an increased risk of developing dementia or cognitive impairment, according to a report in the October issue of Archives of Neurology, one of the JAMA/Archives journals
Read More... |
|
August 17, 2007 12:00 AM
I am writing this article to enlighten those affected by Parkinson's disease, and still employed, about information you need to know about both individual and group insurance products, government insurance programs, how they work, some of the pitfalls, and my advice on how to use all these tools to help develop a long-range insurance plan from now through the rest of your life, considering all the added issues related to having Parkinson's.
Read More... |
|
August 14, 2007 12:00 AM
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that 61 percent of newly diagnosed Parkinson's disease patients do not receive any drug treatment in the first year of diagnosis. According to the new report entitled Treatment Algorithms for Parkinson's Disease, failure of newly diagnosed Parkinson's disease patients to receive pharmacological treatment within the first 12 months of diagnosis likely occurs as a result of patients' decisions to delay treatment until symptoms become sufficiently troublesome. Furthermore, because the guidelines of the American Academy of Neurology (AAN) do not define specific time periods for when treatment should be initiated, patients may be reluctant to begin levodopa therapy, such as with Bristol Myers Squibb's Sinemet, knowing that side-effects will arise, specifically motor response complications.
Read More... |
|
|
